Gideon Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,959
Closed -$1.16M 117
2019
Q4
$1.16M Buy
+7,959
New +$1.15M 0.4% 100
2019
Q3
Sell
-9,830
Closed -$1.46M 349
2019
Q2
$1.46M Buy
+9,830
New +$1.37M 0.5% 66
2018
Q3
Sell
-2,805
Closed -$433K 422
2018
Q2
$433K Sell
2,805
-383
-12% -$57.8K 0.22% 174
2018
Q1
$443K Buy
3,188
+932
+41% +$137K 0.27% 138
2017
Q4
$309K Buy
+2,256
New +$298K 0.27% 159
2017
Q1
Sell
-1,890
Closed -$209K 458
2016
Q4
$209K Buy
+1,890
New +$210K 0.13% 365

Other funds holding LH

Gideon Capital Advisors's LH Position: Q1 2020 in Review

Gideon Capital Advisors sold out of Labcorp (LH) in Q1 2020, closing a stake of 7,959 shares — an estimated $1.16M sold.

Gideon Capital Advisors first reported a position in LH in Q4 2016 and held it in 6 quarters. The position peaked at $1.46M in Q2 2019. 761 funds tracked by Wall St. Rank hold LH as of Q1 2020.

  • Gideon Capital Advisors reported no remaining Labcorp position as of Q1 2020 after selling out during the quarter.
  • Gideon Capital Advisors sold 7,959 Labcorp shares in Q1 2020, an estimated $1.16M.
  • Gideon Capital Advisors first reported a position in Labcorp in Q4 2016 and held it in 6 quarters.
  • Gideon Capital Advisors's Labcorp position peaked at $1.46M in Q2 2019.
  • 761 funds tracked by Wall St. Rank held Labcorp as of Q1 2020.

Based on Gideon Capital Advisors's 13F filing for Q1 2020.